Allogene Therapeutics
Price & Volume
Stats
See more52W Range | $0.86-$3.78 |
Market Cap | $326.1M |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$180M |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 10 days ago
September 2025's Promising Penny Stocks Revealed
Yahoo Finance • last month
Allogene Therapeutics Announces Participation in Upcoming Investor Conference
Yahoo Finance • last month
Discover Promising Penny Stocks This August 2025
Yahoo Finance • 2 months ago
Allogene outlines clinical milestones with MRD data readout planned for first half 2026 as portfolio advances
About
CEO | Dr. David D. Chang M.D., Ph.D. |
CFO | Mr. Geoffrey M. Parker |
Address | 210 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 226 |
